Richard Anthony Silva
CIK: 0002085780
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LB PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Disposition(D)DirectEmployee Stock Option (Right to Buy)
9K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Award(A)DirectEmployee Stock Option (Right to Buy)
9K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Award(A)DirectEmployee Stock Option (Right to Buy)
80.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Disposition(D) Employee Stock Option (Right to Buy) | 8,964 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award(A) Employee Stock Option (Right to Buy) | 8,964 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award(A) Employee Stock Option (Right to Buy) | 80,899 | - | - | Direct |
1-3 of 3 transactions
About Silva Richard Anthony
Silva Richard Anthony (SEC CIK 0002085780) files insider reports with the SEC as SVP, Technical Operations of LB PHARMACEUTICALS INC (LBRX).
Signal8 holds 2 ownership filings by Silva Richard Anthony (1 Form 3, 1 Form 4), filed between Sep 11, 2025 and Sep 12, 2025. Those filings report 3 transactions, the latest on Sep 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Silva Richard Anthony's filings is in NEW YORK, NY.
Recent filings by Silva Richard Anthony
Other insiders filing for LB PHARMACEUTICALS INC (LBRX)
- Miller Joseph M, Chief Financial Officer
- Kozauer Susan Gani, Chief Medical Officer
- Deep Track Biotechnology Master Fund, Ltd., 10% Owner
- RUFFOLO ROBERT R, Director
- Nussbaum Ran, Director
- Luse Rebecca, Director